Encanto - The Power of cartilage.

18/11/2025

🔹 ENCANTO 4th General Assembly – Würzburg, Germany 🇩🇪

Last week, the ENCANTO consortium gathered for the 4th General Assembly, hosted by our partners at the University Hospital of Würzburg.

🔬 We are happy to report that patient recruitment has started in several clinical centers across Europe. After many months of preparation, regulatory work, and site setup, the clinical phase of the project is now officially underway.

💡 With 22 partners from 10 countries, ENCANTO continues to push forward in developing an innovative treatment for patellofemoral osteoarthritis using nasal cartilage (N-TEC technology).

Thanks to all our partners for the inspiring discussions, updates, and great collaboration!

Encanto - The Power of Cartilage

18/09/2025

ENCANTO has reached a major milestone: with full approval now secured across all countries, the first patients have already been recruited at USB and OSS. The journey moves forward with the very first treatment scheduled for 23 September 2025 — a pivotal step in bringing innovation to patients across Europe.

16/09/2025

ENCANTO has reached a major milestone: with full approval now secured across all countries, the first patients have already been recruited at University Hospital Basel and Orthopaedic Hospital Speising in Vienna!

The journey moves forward with the very first treatment scheduled for 23 September 2025 — a pivotal step in bringing innovation to patients across Europe.

25/08/2025

Orthopaedic Hospital Speising in Vienna, serving as Austria’s exclusive trial site, has started patient recruitment for the ENCANTO clinical study.
Curious to learn more in Austrian German language about how nasal cells could pave the way for cartilage regeneration and improved mobility? Check out the latest details from Krone and OTS, and explore how ENCANTO is reshaping the future of knee therapy.

https://www.ots.at/presseaussendung/OTS_20250807_OTS0022/innovative-arthrose-behandlung-nasenzellen-fuers-knie

https://www.krone.at/3855273

Im Rahmen einer EU-weiten Studie namens ENCANTO wird eine innovative Methode erprobt, bei der Zellen aus der Nase zur Behandlung von Kniearthrosen verwendet werden.